AGL — agilon health inc. stock price and chart

AGL

$91.72+3.25%

as of close, Oct 20, 2026

☾ AH $91.72 +3.25%

agilon health inc.Stock · HealthcareRussell 2000 · 0.04% of IWMRussell 3000 · 0.002% of IWVUS Stock Market · 0.002% of VTI

PeersEHCSPYQQQNVDAAAPLMSFT

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Apr 19, 2021

VolumeEEEEEEEEESEE

20212022202420252026

100.0200.0300.0400.0500.0600.0700.0800.0900.01000.005.0M$91.72

2026-10-20

Price$91.72

MA20$89.36

MA50$78.07

Vol506.1K

What would $1,000 invested in AGL be worth today? →

AGL returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $91.72
YTD price return: +432.48%
YTD total return: +432.48%
Next earnings: Nov 4, 2026 · After close
Market cap: 1.5B2021-06 15.9B2026-10 1.5B-90.3% over the window
Enterprise value: 1.5B
Shares outstanding: 16.8M2020-12 10M2026-06 16.8M+68.3% over the window
52W low: $7.48
52W high: $133.04
From 52W high: -31.06%
From 52W low: +1126.20%
52W range: 67%

Volume

Rel volume: 0.76×
30D volume: 218.1K
30D $ vol: 18.7M

Fundamentals

Sales (ttm): 5.9B2019-12 794.4M2026-06 5.9B+645.2% over the window
Sales/share: $352.572020-12 $122.142026-06 $352.57+188.7% over the window
EPS (ttm): -$13.862020-12 -$4.642026-06 -$13.86+198.5% over the window
FCF (ttm): -85M2019-12 -106.8M2026-06 -85M-20.4% over the window
FCF/share: -$5.062020-12 -$5.512026-06 -$5.06-8.2% over the window
Book value/share: $13.552020-06 -$24.892026-06 $13.55-154.4% over the window
Net margin: -3.92%2019-12 -35.6%2026-06 -3.9%-89.0% over the window
ROE: -102.06%2021-06 -30.4%2026-06 -102.1%+235.5% over the window
ROA: -14.59%2020-12 -13.5%2026-06 -14.6%+8.5% over the window
Debt / equity: 0.07×2021-06 0.042026-06 0.07+69.5% over the window
Current ratio: 1.082020-12 1.102026-06 1.08-2.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +0.32%2025-06-30 → 2026-06-305.9B → 5.9B (+0.3% total)+22.91%2023-06-30 → 2026-06-303.2B → 5.9B (+85.7% total)+30.81%2021-06-30 → 2026-06-301.5B → 5.9B (+283.0% total)n/a
Shares: +1.29%2025-06-30 → 2026-06-3016.6M → 16.8M (+1.3% total)+1.16%2023-06-30 → 2026-06-3016.2M → 16.8M (+3.5% total)+1.44%2021-06-30 → 2026-06-3015.6M → 16.8M (+7.4% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: -0.96%2025-06-30 → 2026-06-30$355.99 → $352.57 (-1.0% total)+21.50%2023-06-30 → 2026-06-30$196.56 → $352.57 (+79.4% total)+28.96%2021-06-30 → 2026-06-30$98.86 → $352.57 (+256.6% total)n/a
Book value/share: -45.09%2025-06-30 → 2026-06-30$24.67 → $13.55 (-45.1% total)-37.02%2023-06-30 → 2026-06-30$54.27 → $13.55 (-75.0% total)-28.71%2021-06-30 → 2026-06-30$73.58 → $13.55 (-81.6% total)n/a
Price: +270.92%2025-10-20 → 2026-10-20$24.75 → $91.72 (+270.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-42.53%2023-10-20 → 2026-10-20$483.50 → $91.72 (-81.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-31.32%2021-10-20 → 2026-10-20$600.00 → $91.72 (-84.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +270.92%2025-10-20 → 2026-10-20$24.75 → $91.72 (+270.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-42.53%2023-10-20 → 2026-10-20$483.50 → $91.72 (-81.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-31.32%2021-10-20 → 2026-10-20$600.00 → $91.72 (-84.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -6.6×2021-06 -45.312026-10 -6.63-85.4% over the window
Fwd P/E: 36.9×
P/S (ttm)Market cap ÷ TTM revenue.: 0.3×2021-06 10.262026-10 0.26-97.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 6.8×2021-06 13.782026-10 6.77-50.9% over the window
EV/Sales (ttm): 0.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -5.52%2021-03 -0.4%2026-06 -4.7%+976.9% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2021-03 0.0%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.5B). Same caveat as the cash buyback yield.: 0.00%2021-03 0.0%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S: 30th
P/B: 55th

Bar = where today’s multiple sits in AGL’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+3.25%

+6.78%

+2.87%

-24.88%

YTD

+432.48%

+270.59%

-84.71%

Financial statements

Open full AGL financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

AGL — agilon health inc. price, chart and key statistics